Blackrock Pharmaceuticals is a rapidly expanding company focused on the development and marketing of high quality, specialist generic medicines. We have strong and established presence in the UK and partnerships in many European markets. Our team of pharmaceutical industry experts are highly experienced, dedicated and professional. We offer quality focused expertise covering all EU regulatory licensing activities; EU QP release and Sales and Marketing activities. Our product development is focused on understanding and meeting unmet patient needs. The Blackrock pipeline contains over 10 pharmaceutical products in various stages of development and registration, and covers many therapeutic disease areas including: Antispasmodics; Antidepressants; Antithyroid; Rheumatic disease; Bowel disease and Diabetes. With extensive regulatory, quality and commercial expertise, we are also a trusted partner for manufacturers to increase product revenues, through launches into new geographies. If you are interested in partnering with Blackrock Pharmaceuticals, please contact Rupert.Davies@blackrockpharma.com